The combination of maternal blood and amniotic fluid biomarkers improves the predictive accuracy of histologic chorioamnionitis
MIYAMOTO Shingo; KURAKAZU Masamitsu; YOTSUMOTO Fusanori; ARIMA Hisatomi; IZUCHI Daisuke; URUSHIYAMA Daichi; MIYATA Kohei; KIYOSHIMA Chihiro; FUKAGAWA Satoshi; YOSHIKAWA Ken-Ichi; HIRAKAWA Toyofumi; SHIGEKAWA Koichiro; SANUI Ayako; NABESHIMA Kazuki
Placenta, 2019, 80:4 - 7

Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
MIYAMOTO Shingo; IZUCHI Daisuke; FUKAGAWA Satoshi; YOTSUMOTO Fusanori; YOSHIKAWA Ken-Ichi; KIYOSHIMA Chihiro; NAN Son-U; MIYATA Kohei; ITO Tomohiro; KURAKAZU Masamitsu; ARAKI Ryota; SANUI Ayako; MIYAHARA Daisuke; MURATA Masaharu
Anticancer Res, 2018, 38(7):4347 - 4351, Refereed

Microbiome profile of the amniotic fluid as a predictive biomarker of perinatal outcome
MIYAMOTO Shingo; ARAKI Ryota; KIYOSHIMA Chihiro; KURAKAZU Masamitsu; SANUI Ayako; YOTSUMOTO Fusanori; MURATA Masaharu
Scientific Report, 22 Sep. 2017, Refereed

Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
Kohei Miyata; Fusanori Yotsumoto; Satoshi Fukagawa; Chihiro Kiyoshima; Nam Sung Ouk; Daichi Urushiyama; Tomohiro Ito; Takahiro Katsuda; Masamitsu Kurakazu; Ryota Araki; Ayako Sanui; Daisuke Miyahara; Masaharu Murata; Kyoko Shirota; Hiroshi Yagi; Tadao Takono; Kiyoko Kato; Nobuo Yaegashi; Kohei Akazawa; Masahide Kuroki; ShiN'Ichiro Yasunaga; Shingo Miyamoto
ANTICANCER RESEARCH, Jul. 2017, 37(7):3955 - 3960, Refereed

BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study
MIYAMOTO Shingo; YOTSUMOTO Fusanori; SANUI Ayako
BMC Cancer, 31 Jan. 2017, 17, Refereed